Literature DB >> 15243811

Steroid-sparing effect of tacrolimus in a patient with juvenile dermatomyositis presenting poor bioavailability of cyclosporine A.

Akiko Yamada1, Yusei Ohshima, Nemuko Omata, Motoko Yasutomi, Mitsufumi Mayumi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15243811     DOI: 10.1007/s00431-004-1497-7

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  3 in total

Review 1.  FK 506: a novel immunosuppressant for treatment of autoimmune disease. Rationale and preliminary clinical experience at the University of Pittsburgh.

Authors:  A W Thomson; P B Carroll; J McCauley; J Woo; K Abu-Elmagd; T E Starzl; D H Van Thiel
Journal:  Springer Semin Immunopathol       Date:  1993

Review 2.  Cyclosporin pharmacokinetics in paediatric transplant recipients.

Authors:  G F Cooney; K Habucky; K Hoppu
Journal:  Clin Pharmacokinet       Date:  1997-06       Impact factor: 6.447

3.  Cyclosporin a therapy in refractory juvenile dermatomyositis. Experience and longterm followup of 6 cases.

Authors:  V Zeller; P Cohen; A M Prieur; L Guillevin
Journal:  J Rheumatol       Date:  1996-08       Impact factor: 4.666

  3 in total
  6 in total

1.  Therapeutic advances and future prospects in immune-mediated inflammatory myopathies.

Authors:  Marinos C Dalakas
Journal:  Ther Adv Neurol Disord       Date:  2008-11       Impact factor: 6.570

Review 2.  Immunotherapy of myositis: issues, concerns and future prospects.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Rheumatol       Date:  2010-02-02       Impact factor: 20.543

Review 3.  Treatment of Calcinosis in Juvenile Dermatomyositis.

Authors:  Ovgu Kul Cinar; Charalampia Papadopoulou; Clarissa A Pilkington
Journal:  Curr Rheumatol Rep       Date:  2021-02-08       Impact factor: 4.592

Review 4.  Juvenile dermatomyositis: advances in pathogenesis, evaluation, and treatment.

Authors:  Adam M Huber
Journal:  Paediatr Drugs       Date:  2009       Impact factor: 3.022

5.  Treatment of refractory juvenile dermatomyositis with tacrolimus.

Authors:  Jihaan Hassan; Jan Jaap van der Net; Annet van Royen-Kerkhof
Journal:  Clin Rheumatol       Date:  2008-08-21       Impact factor: 2.980

6.  Autoimmune neuromuscular disorders in childhood.

Authors:  Hugh J McMillan; Basil T Darras; Peter B Kang
Journal:  Curr Treat Options Neurol       Date:  2011-12       Impact factor: 3.598

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.